Memory Resilience in Alzheimer Disease With Primary Progressive Aphasia.
Aged
Alzheimer Disease
/ pathology
Amnesia
/ pathology
Aphasia, Primary Progressive
/ pathology
Apolipoprotein E4
/ genetics
Atrophy
Autopsy
DNA-Binding Proteins
/ metabolism
Disease Progression
Entorhinal Cortex
/ pathology
Female
Hippocampus
/ pathology
Humans
Longitudinal Studies
Male
Memory, Episodic
Middle Aged
Neurofibrillary Tangles
/ pathology
Severity of Illness Index
Journal
Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060
Informations de publication
Date de publication:
09 02 2021
09 02 2021
Historique:
received:
01
07
2020
accepted:
25
09
2020
pubmed:
15
1
2021
medline:
24
2
2021
entrez:
14
1
2021
Statut:
ppublish
Résumé
To determine whether memory is preserved longitudinally in primary progressive aphasia (PPA) associated with Alzheimer disease (AD) and to identify potential factors that maintain memory despite underlying neurofibrillary degeneration of mediotemporal memory areas. Longitudinal memory assessment was done in 17 patients with PPA with autopsy or biomarker evidence of AD (PPA-AD) and 14 patients with amnestic dementia of the Alzheimer type with AD at autopsy (DAT-AD). In PPA-AD, episodic memory, tested with nonverbal items, was preserved at the initial testing and showed no decline at retesting 2.35 ± 0.78 years later, at which time symptoms had been present for 6.26 ± 2.21 years. In contrast, language functions declined significantly during the same period. In DAT-AD, both verbal memory and language declined with equal severity. Although imaging showed asymmetric left-sided mediotemporal atrophy in PPA-AD, autopsy revealed bilateral hippocampo-entorhinal neurofibrillary degeneration at Braak stages V and VI. Compared to DAT-AD, however, the PPA-AD group had lower incidence of Memory preservation in PPA is not just an incidental finding at onset but a core feature that persists for years despite the hippocampo-entorhinal AD neuropathology that is as severe as that of DAT-AD. Asymmetry of mediotemporal atrophy and a lesser impact of NCT00537004 and NCT03371706.
Identifiants
pubmed: 33441454
pii: WNL.0000000000011397
doi: 10.1212/WNL.0000000000011397
pmc: PMC8105903
doi:
Substances chimiques
Apolipoprotein E4
0
DNA-Binding Proteins
0
TARDBP protein, human
0
Banques de données
ClinicalTrials.gov
['NCT00537004', 'NCT03371706']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e916-e925Subventions
Organisme : NIA NIH HHS
ID : K08 AG065463
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC008552
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS075075
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072977
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG062566
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG013854
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG056258
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 American Academy of Neurology.
Références
Dement Geriatr Cogn Disord. 2007;24(2):98-103
pubmed: 17596691
J Nucl Med. 2012 Mar;53(3):378-84
pubmed: 22331215
Brain. 2019 Jun 1;142(6):1503-1527
pubmed: 31039256
Ann Neurol. 2001 Apr;49(4):425-32
pubmed: 11310619
Brain. 2014 Apr;137(Pt 4):1176-92
pubmed: 24574501
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
Neurology. 2020 Feb 11;94(6):e607-e612
pubmed: 31704790
Neurobiol Aging. 1997 Jul-Aug;18(4):351-7
pubmed: 9330961
Brain Pathol. 2020 Mar;30(2):332-344
pubmed: 31446630
Br J Clin Psychol. 1990 Nov;29(4):353-60
pubmed: 2289071
Acta Neuropathol Commun. 2015 Jun 20;3:35
pubmed: 26091809
Brain. 2012 May;135(Pt 5):1554-65
pubmed: 22522938
Neurology. 2020 Feb 18;94(7):e699-e704
pubmed: 31969462
Alzheimers Dement. 2019 Apr;15(4):543-552
pubmed: 30765195
Neuroscience. 1999;91(3):1009-16
pubmed: 10391478
JAMA Neurol. 2016 Jul 1;73(7):846-52
pubmed: 27183206
Neuroimage. 2002 Apr;15(4):870-8
pubmed: 11906227
Lancet Neurol. 2011 Sep;10(9):785-96
pubmed: 21802369
Acta Neuropathol. 2010 Jul;120(1):43-54
pubmed: 20361198
JAMA Neurol. 2013 Nov;70(11):1418-24
pubmed: 24080705
Neurology. 2017 Feb 14;88(7):653-660
pubmed: 28087828
Cortex. 2020 Apr;125:272-287
pubmed: 32061945
Trends Neurosci. 1994 Dec;17(12):525-30
pubmed: 7532337
Dement Geriatr Cogn Disord. 2005;19(5-6):331-7
pubmed: 15785034
Acta Neuropathol. 2014;127(6):811-24
pubmed: 24659241
Brain Res. 2002 Feb 22;928(1-2):96-105
pubmed: 11844476
Hippocampus. 2019 May;29(5):458-467
pubmed: 29341318
Neurology. 2016 Sep 27;87(13):1337-43
pubmed: 27566743
Sci Transl Med. 2020 Jan 1;12(524):
pubmed: 31894103
Neurosci Biobehav Rev. 2018 Sep;92:243-254
pubmed: 29928907
Ann Neurol. 2018 Mar;83(3):599-611
pubmed: 29451323
Ann Neurol. 1998 Aug;44(2):288-91
pubmed: 9708558
Brain. 2016 May;139(Pt 5):1551-67
pubmed: 26962052
JAMA Neurol. 2017 Apr 1;74(4):427-436
pubmed: 28241163
Alzheimers Dement. 2015 Jan;11(1):58-69
pubmed: 24795085
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
J Clin Exp Neuropsychol. 1989 Dec;11(6):855-70
pubmed: 2592527
Int J Clin Exp Pathol. 2011 Jan 30;4(2):147-55
pubmed: 21326809
J Nucl Med. 2018 Feb;59(2):299-306
pubmed: 28747523
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Cereb Cortex. 2009 Mar;19(3):497-510
pubmed: 18632739
N Engl J Med. 2000 Aug 17;343(7):450-6
pubmed: 10944562
Acta Neuropathol. 2019 Oct;138(4):597-612
pubmed: 31250152